RxSight (RXST) Chief Business Dev. Officer Eric Weinberg Exercises Options

What Happened
Eric Weinberg, Chief Business Development Officer of RxSight (RXST), exercised stock options (code M) on 2026-09-15 to acquire 35,168 shares at $4.34 per share for a cash cost of approximately $152,629. The filing also shows a companion derivative entry for 35,168 shares at $0.00; the reporting person notes the shares are held by the EJW Living Trust (for which he is trustee). Footnote indicates the options were fully vested and exercisable.

Key Details

• Transaction date: 2026-09-15; filing date: 2026-09-16 (timely filing).
• Exercise: 35,168 shares acquired at $4.34 each; total cash paid ~$152,629.
• Companion derivative entry: 35,168 shares disposed at $0.00 (reported as a derivative conversion/transfer).
• Footnotes: F1 — shares held by the EJW Living Trust (Weinberg is trustee); F2 — options were fully vested and exercisable.
• Shares owned after the transaction: not specified in the Form 4.

Context

• This was an option exercise (code M). The paired $0.00 derivative entry often reflects conversion/transfer mechanics (e.g., delivery to a trust or internal accounting) rather than an open-market sale; the filing does not show a market sale of the shares.
• Exercises are routine for vested option holders and represent acquisition of stock rather than a sale; they do not, by themselves, indicate the insider’s view of the company’s prospects.